A Possible Relationship Between Testosterone and Lower Urinary Tract Symptoms in Men

Journal of Urology

Volumn 182, Issue 1, 2009, Pages 215-220

  Chang, In Ho ^a   Oh, Seung Young ^a   Kim, Sae Chul ^a  

^a Chung Ang University   (South Korea)

Author keywords

insulin resistance; signs and symptoms; testosterone; urinary tract

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; GLUCOSE; INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MICTURITION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TESTOSTERONE BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE PROGRESSION; HUMANS; INSULIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; URINATION DISORDERS; URODYNAMICS;

EID: 67349095894     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.02.123     Document Type: Article

References (29)

1. Berry S.J., Coffey D.S., Walsh P.C., and Ewing L.L. The development of human benign prostatic hyperplasia with age. J Urol 132 (1984) 474
2. Partin A.W., Oesterling J.E., Epstein J.I., Horton R., and Walsh P.C. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 145 (1991) 405
3. Montie J.E., and Pienta K.J. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. Urology 43 (1994) 892
4. Bruchovsky N., Rennie P.S., Batzold F.H., Goldenberg S.L., Fletcher T., and McLoughlin M.G. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates. J Clin Endocrinol Metab 67 (1988) 806
5. Barrack E.R., Bujnovszky P., and Walsh P.C. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors. Cancer Res 43 (1983) 1107
6. Barry M.J., Cockett A.T., Holtgrewe H.L., McConnell J.D., Sihelnik S.A., and Winfield H.N. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 150 (1993) 351
7. McVary K.T., Rademaker A., Lloyd G.L., and Gann P. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 174 (2005) 1327
8. Kasturi S., Russell S., and McVary K.T. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep 7 (2006) 288
9. Rohrmann S., De Marzo A.M., Smit E., Giovannucci E., and Platz E.A. Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III). Prostate 62 (2005) 27
10. Teoh H., and Verma S. C-reactive protein, metabolic syndrome, and end organ damage. Metabolism 56 (2007) 1620
11. Wallace T.M., and Matthews D.R. The assessment of insulin resistance in man. Diabet Med 19 (2002) 527
12. Fultz N.H., and Herzog A.R. Epidemiology of urinary symptoms in the geriatric population. Urol Clin North Am 23 (1996) 1
13. Rohrmann S., Smit E., Giovannucci E., and Platz E.A. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) 29 (2005) 310
14. Bjorntorp P., and Rosmond R. The metabolic syndrome-a neuroendocrine disorder?. Br J Nutr 83 (2000) S49
15. Rosmond R., Dallman M.F., and Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83 (1998) 1853
16. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23 (2000) 57
17. Saad F., Gooren L.J., Haider A., and Yassin A. A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl 29 (2008) 102
18. Kalinchenko S., Vishnevskiy E.L., Koval A.N., Mskhalaya G.J., and Saad F. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study. Aging Male 11 (2008) 57
19. Koritsiadis G., Stravodimos K., Mitropoulos D., Doumanis G., Fokitis I., Koritsiadis S., et al. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study. BJU Int 101 (2008) 1542
20. Traish A.M., Park K., Dhir V., Kim N.N., Moreland R.B., and Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 140 (1999) 1861
21. Ehren I., Iversen H., Jansson O., Adolfsson J., and Wiklund N.P. Localization of nitric oxide synthase activity in the human lower urinary tract and its correlation with neuroeffector responses. Urology 44 (1994) 683
22. Kimura N., Mizokami A., Oonuma T., Sasano H., and Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem 41 (1993) 671
23. Azadzoi K.M., Tarcan T., Siroky M.B., and Krane R.J. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit. J Urol 161 (1999) 1626
24. Levin R.M., Levin S.S., Zhao Y., and Buttyan R. Cellular and molecular aspects of bladder hypertrophy. Eur Urol 32 (1997) 15
25. Gill H.S., Monson F.C., Wein A.J., Ruggieri M.R., and Levin R.M. The effects of short-term in-vivo ischemia on the contractile function of the rabbit urinary bladder. J Urol 139 (1988) 1350
26. Svartberg J., von Muhlen D., Mathiesen E., Joakimsen O., Bonaa K.H., and Stensland-Bugge E. Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 259 (2006) 576
27. Miner M.M., and Sadovsky R. Evolving issues in male hypogonadism: evaluation, management, and related comorbidities. Cleve Clin J Med 74 (2007) S38
28. Blouin K., Richard C., Brochu G., Hould F.S., Lebel S., Marceau S., et al. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men. J Endocrinol 191 (2006) 637
29. Kapoor D., Goodwin E., Channer K.S., and Jones T.H. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154 (2006) 899